United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals llc - telmisartan (unii: u5syw473rq) (telmisartan - unii:u5syw473rq) - telmisartan 20 mg - telmisartan tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of

United States - English - NLM (National Library of Medicine)

micro labs limited - telmisartan (unii: u5syw473rq) (telmisartan - unii:u5syw473rq) - telmisartan 20 mg - telmisartan tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - telmisartan, amlodipine - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension in adults:add-on therapytwynsta is indicated in adults whose blood pressure is not adequately controlled on amlodipine.replacement therapyadult patients receiving telmisartan and amlodipine from separate tablets can instead receive tablets of twynsta containing the same component doses.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - telmisartan, quantity: 80 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, film coated - excipient ingredients: sodium hydroxide; titanium dioxide; povidone; hypromellose; meglumine; mannitol; magnesium stearate; propylene glycol; purified water; isopropyl alcohol; iron oxide black - treatment of hypertension. treatment should not be initiated with this fixed-dose combination. (see dosage and administration)

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg); telmisartan, quantity: 80 mg - tablet, film coated - excipient ingredients: meglumine; titanium dioxide; hypromellose; sodium hydroxide; povidone; magnesium stearate; mannitol; propylene glycol; purified water; isopropyl alcohol; iron oxide black - treatment of hypertension. treatment should not be initiated with this fixed-dose combination. (see dosage and administration)

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - telmisartan, quantity: 40 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: meglumine; povidone; sodium hydroxide; hypromellose; titanium dioxide; mannitol; magnesium stearate; propylene glycol; purified water; isopropyl alcohol; iron oxide black - treatment of hypertension. treatment should not be initiated with this fixed-dose combination. (see dosage and administration)

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); telmisartan, quantity: 80 mg - tablet, film coated - excipient ingredients: meglumine; magnesium stearate; titanium dioxide; hypromellose; sodium hydroxide; mannitol; povidone; propylene glycol; purified water; isopropyl alcohol; iron oxide black - treatment of hypertension. treatment should not be initiated with this fixed-dose combination. (see dosage and administration)

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - telmisartan, quantity: 80 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: hypromellose; meglumine; sodium hydroxide; povidone; mannitol; magnesium stearate; titanium dioxide; propylene glycol; purified water; isopropyl alcohol; iron oxide black - treatment of hypertension. treatment should not be initiated with this fixed-dose combination. (see dosage and administration)

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg); telmisartan, quantity: 40 mg - tablet, film coated - excipient ingredients: titanium dioxide; sodium hydroxide; magnesium stearate; mannitol; meglumine; hypromellose; povidone; propylene glycol; purified water; isopropyl alcohol; iron oxide black - treatment of hypertension. treatment should not be initiated with this fixed-dose combination. (see dosage and administration)

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); telmisartan, quantity: 40 mg - tablet, film coated - excipient ingredients: titanium dioxide; sodium hydroxide; meglumine; mannitol; hypromellose; povidone; magnesium stearate; propylene glycol; purified water; isopropyl alcohol; iron oxide black - treatment of hypertension. treatment should not be initiated with this fixed-dose combination. (see dosage and administration)